CHARLES H HOOD FOUNDATION: Form 990PF, tax year 2024

View the entire original 990 at ProPublica ↗

Organization
CHARLES H HOOD FOUNDATION (EIN 04-3507847)
Tax period
2024-01-01 to 2024-12-31
Filed
2025-11-12
IRS object ID
202533169349100728
Schema version
2024v5.2
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2025-11-12T09:10:56-06:00ReturnTs
Tax Period End2024-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN042571780PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1AAFCPAS INCBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line150 WASHINGTON STREETAddressLine1Txt
CityWESTBOROUGHCityNm
State AbbreviationMAStateAbbreviationCd
ZIP01581ZIPCd
FieldValueIRS element (for citing)
Return Type990PFReturnTypeCd
Tax Period Begin2024-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN043507847EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1CHARLES H HOOD FOUNDATIONBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlCHARBusinessNameControlTxt
Phone6172792230PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line129 OLD NECK ROADAddressLine1Txt
CityMANCHESTERBYTHESEACityNm
State AbbreviationMAStateAbbreviationCd
ZIP01944ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonNEIL SMILEYPersonNm
Person TitlePRESIDENT AND TREASURERPersonTitleTxt
Phone6172792230PhoneNum
Signature2025-11-11SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd
FieldValueIRS element (for citing)
IRS Responsible Prty Info CurrYes (1)IRSResponsiblePrtyInfoCurrInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonJOYCE RIPIANZI CPAPreparerPersonNm
PTINP00548581PTIN
Phone5083669100PhoneNum
Preparation2025-11-11PreparationDt
FieldValueIRS element (for citing)
Tax2024TaxYr
Build TS2025-03-06 01:10:19ZBuildTS

Form 990-PF IRS990PF

FieldValueIRS element (for citing)
Address ChangeYes (X)AddressChangeInd
Organization501c3 Exempt PFYes (X)Organization501c3ExemptPFInd
FMV Assets EOY$101,037,612FMVAssetsEOYAmt
Method Of Accounting CashYes (X)MethodOfAccountingCashInd

Analysis Of Revenue And Expenses AnalysisOfRevenueAndExpenses

FieldValueIRS element (for citing)
Contri Rcvd Rev And Expnss$21,668,457ContriRcvdRevAndExpnssAmt
Dividends Rev And Expnss$2,066,610DividendsRevAndExpnssAmt
Dividends Net Invst Incm$2,003,473DividendsNetInvstIncmAmt
Net Gain Sale Ast Rev And Expnss$4,246,783NetGainSaleAstRevAndExpnssAmt
Gross Sales Price$15,346,535GrossSalesPriceAmt
Cap Gain Net Incm Net Invst Incm$4,246,783CapGainNetIncmNetInvstIncmAmt
Incm Modifications Adj Net Incm$26,256IncmModificationsAdjNetIncmAmt
Other Income Rev And Expnss$208,682OtherIncomeRevAndExpnssAmt
Other Income Net Invst Incm$181,544OtherIncomeNetInvstIncmAmt
Total Rev And Expnss$28,190,532TotalRevAndExpnssAmt
Total Net Invst Incm$6,431,800TotalNetInvstIncmAmt
Total Adj Net Incm$26,256TotalAdjNetIncmAmt
Comp Ofcr Dir Trst Rev And Expnss$0CompOfcrDirTrstRevAndExpnssAmt
Comp Ofcr Dir Trst Net Invst Incm$0CompOfcrDirTrstNetInvstIncmAmt
Comp Ofcr Dir Trst Dsbrs Chrtbl$0CompOfcrDirTrstDsbrsChrtblAmt
Legal Fees Rev And Expnss$20,204LegalFeesRevAndExpnssAmt
Legal Fees Net Invst Incm$0LegalFeesNetInvstIncmAmt
Legal Fees Dsbrs Chrtbl$20,204LegalFeesDsbrsChrtblAmt
Accounting Fees Rev And Expnss$29,863AccountingFeesRevAndExpnssAmt
Accounting Fees Net Invst Incm$0AccountingFeesNetInvstIncmAmt
Accounting Fees Chrtbl Prps$29,863AccountingFeesChrtblPrpsAmt
Other Prof Fees Rev And Expnss$116,380OtherProfFeesRevAndExpnssAmt
Other Prof Fees Net Invst Incm$97,565OtherProfFeesNetInvstIncmAmt
Other Prof Fees Dsbrs Chrtbl$18,815OtherProfFeesDsbrsChrtblAmt
Taxes Rev And Expnss$146,252TaxesRevAndExpnssAmt
Taxes Net Invst Incm$40,752TaxesNetInvstIncmAmt
Taxes Dsbrs Chrtbl$500TaxesDsbrsChrtblAmt
Trav Conf Meeting Rev And Expnss$16,265TravConfMeetingRevAndExpnssAmt
Trav Conf Meeting Net Invst Incm$0TravConfMeetingNetInvstIncmAmt
Trav Conf Meeting Dsbrs Chrtbl$16,265TravConfMeetingDsbrsChrtblAmt
Other Expenses Rev And Expnss$360,097OtherExpensesRevAndExpnssAmt
Other Expenses Net Invst Incm$0OtherExpensesNetInvstIncmAmt
Other Expenses Dsbrs Chrtbl$360,097OtherExpensesDsbrsChrtblAmt
Tot Opr Expenses Rev And Expnss$689,061TotOprExpensesRevAndExpnssAmt
Tot Opr Expenses Net Invst Incm$138,317TotOprExpensesNetInvstIncmAmt
Tot Opr Expenses Dsbrs Chrtbl$445,744TotOprExpensesDsbrsChrtblAmt
Contri Paid Rev And Expnss$2,470,000ContriPaidRevAndExpnssAmt
Contri Paid Dsbrs Chrtbl$2,470,000ContriPaidDsbrsChrtblAmt
Total Expenses Rev And Expnss$3,159,061TotalExpensesRevAndExpnssAmt
Total Expenses Net Invst Incm$138,317TotalExpensesNetInvstIncmAmt
Total Expenses Dsbrs Chrtbl$2,915,744TotalExpensesDsbrsChrtblAmt
Excess Revenue Over Expenses$25,031,471ExcessRevenueOverExpensesAmt
Net Investment Income$6,293,483NetInvestmentIncomeAmt
Adjusted Net Income$26,256AdjustedNetIncomeAmt

Form990 PF Balance Sheets Form990PFBalanceSheetsGrp

FieldValueIRS element (for citing)
Sav And Temp Cash Invst BOY$204,648SavAndTempCashInvstBOYAmt
Sav And Temp Cash Invst EOY$7,779,857SavAndTempCashInvstEOYAmt
Sav And Temp Cash Invst EOYFMV$7,779,857SavAndTempCashInvstEOYFMVAmt
Corporate Stock BOY$35,440,583CorporateStockBOYAmt
Corporate Stock EOY$47,342,703CorporateStockEOYAmt
Corporate Stock EOYFMV$47,342,703CorporateStockEOYFMVAmt
Corporate Bonds BOY$13,614,650CorporateBondsBOYAmt
Corporate Bonds EOY$17,658,588CorporateBondsEOYAmt
Corporate Bonds EOYFMV$17,658,588CorporateBondsEOYFMVAmt
Other Investments BOY$18,742,212OtherInvestmentsBOYAmt
Other Investments EOY$23,677,157OtherInvestmentsEOYAmt
Other Investments EOYFMV$23,677,157OtherInvestmentsEOYFMVAmt
Other Assets BOY$4,006,057OtherAssetsBOYAmt
Other Assets EOY$4,579,307OtherAssetsEOYAmt
Other Assets EOYFMV$4,579,307OtherAssetsEOYFMVAmt
Total Assets BOY$72,008,150TotalAssetsBOYAmt
Total Assets EOY$101,037,612TotalAssetsEOYAmt
Total Assets EOYFMV$101,037,612TotalAssetsEOYFMVAmt
Total Liabilities BOY$0TotalLiabilitiesBOYAmt
Total Liabilities EOY$0TotalLiabilitiesEOYAmt
Org Does Not Follow FASB117Yes (X)OrgDoesNotFollowFASB117Ind
Capital Stock BOY$59,300,755CapitalStockBOYAmt
Capital Stock EOY$59,300,755CapitalStockEOYAmt
Additional Paid In Capital BOY$0AdditionalPaidInCapitalBOYAmt
Additional Paid In Capital EOY$0AdditionalPaidInCapitalEOYAmt
Retained Earning BOY$12,707,395RetainedEarningBOYAmt
Retained Earning EOY$41,736,857RetainedEarningEOYAmt
Tot Net Ast Or Fund Balances BOY$72,008,150TotNetAstOrFundBalancesBOYAmt
Tot Net Ast Or Fund Balances EOY$101,037,612TotNetAstOrFundBalancesEOYAmt
Total Liabilities Net Ast BOY$72,008,150TotalLiabilitiesNetAstBOYAmt
Total Liabilities Net Ast EOY$101,037,612TotalLiabilitiesNetAstEOYAmt

Chg In Net Assets Fund Balances ChgInNetAssetsFundBalancesGrp

FieldValueIRS element (for citing)
Tot Net Ast Or Fund Balances BOY$72,008,150TotNetAstOrFundBalancesBOYAmt
Excess Revenue Over Expenses$25,031,471ExcessRevenueOverExpensesAmt
Other Increases$3,997,991OtherIncreasesAmt
Subtotal$101,037,612SubtotalAmt
Other Decreases$0OtherDecreasesAmt
Tot Net Ast Or Fund Balances EOY$101,037,612TotNetAstOrFundBalancesEOYAmt

Cap Gains Loss Tx Invst Incm Detail CapGainsLossTxInvstIncmDetail

Cap Gains Loss Tx Invst Incm CapGainsLossTxInvstIncmGrp (2 entries)

PropertyPropertyDescGross Sales PriceGrossSalesPriceAmtCost Or Other BasisCostOrOtherBasisAmtGain Or LossGainOrLossAmtGains Minus Excess Or LossesGainsMinusExcessOrLossesAmtHow AcquiredHowAcquiredCd
PUBLICLY TRADED SECURITIES$15,202,459$11,099,752$4,102,707$4,102,707
CAPITAL GAINS DIVIDENDS$144,076$144,076$144,076P
FieldValueIRS element (for citing)
Capital Gain Net Income$4,246,783CapitalGainNetIncomeAmt

Excise Tax Based On Invst Incm ExciseTaxBasedOnInvstIncmGrp

FieldValueIRS element (for citing)
Investment Income Excise Tax$87,479InvestmentIncomeExciseTaxAmt
Tax Under Section511$0TaxUnderSection511Amt
Subtotal$87,479SubtotalAmt
Subtitle A Tax$0SubtitleATaxAmt
Tax Based On Investment Income$87,479TaxBasedOnInvestmentIncomeAmt
Estimated Plus Ovpmt Incm Tx$106,335EstimatedPlusOvpmtIncmTxAmt
Exempt Frgn Org Tax Wthld At Srce$0ExemptFrgnOrgTaxWthldAtSrceAmt
Extsn Request Income Tax Paid$0ExtsnRequestIncomeTaxPaidAmt
Backup Withholding Withheld$0BackupWithholdingWithheldAmt
Total Payments And Credits$106,335TotalPaymentsAndCreditsAmt
Form2220 AttachedYes (X)Form2220AttachedInd
Es Penalty$0EsPenaltyAmt
Overpayment$18,856OverpaymentAmt
Applied To ES Tax$18,856AppliedToESTaxAmt
Refund$0RefundAmt

Statements Regarding Acty StatementsRegardingActyGrp

FieldValueIRS element (for citing)
Legislative Political Acty0LegislativePoliticalActyInd
More Than100 Spent0MoreThan100SpentInd
Form1120 POL Filed0Form1120POLFiledInd
Section4955 Organization Tax$0Section4955OrganizationTaxAmt
Section4955 Managers Tax$0Section4955ManagersTaxAmt
Tax Reimbursed$0TaxReimbursedAmt
Activities Not Previously Rpt0ActivitiesNotPreviouslyRptInd
Changes To Articles Or Bylaws0ChangesToArticlesOrBylawsInd
Unrelated Bus Incm Over Limit0UnrelatedBusIncmOverLimitInd
Organization Dissolved Etc0OrganizationDissolvedEtcInd
Section508e Rqr SatisfiedYes (1)Section508eRqrSatisfiedInd
At Least5000 In AssetsYes (1)AtLeast5000InAssetsInd
Org Report Or Register StateMAOrgReportOrRegisterStateCd
Form990 PF Filed With Atty GenYes (1)Form990PFFiledWithAttyGenInd
Private Operating Foundation0PrivateOperatingFoundationInd
New Substantial Contributors0NewSubstantialContributorsInd
Own Controlled EntityYes (1)OwnControlledEntityInd
Donor Advised Fund0DonorAdvisedFundInd
Comply With Public Insp RqrYes (1)ComplyWithPublicInspRqrInd
Website AddressHTTPS://HRIA.ORG/TMF/HOOD/WebsiteAddressTxt
Individual With BooksAAFCPAS INCIndividualWithBooksNm
Phone5083669100PhoneNum

Location Of Books US Address LocationOfBooksUSAddress

FieldValueIRS element (for citing)
Address Line150 WASHINGTON STREETAddressLine1Txt
CityWESTBOROUGHCityNm
State AbbreviationMAStateAbbreviationCd
ZIP01581ZIPCd
FieldValueIRS element (for citing)
Foreign Accounts Question0ForeignAccountsQuestionInd

Statements Regarding Acty4720 StatementsRegardingActy4720Grp

FieldValueIRS element (for citing)
Sale Or Exch Disqualified Prsn0SaleOrExchDisqualifiedPrsnInd
Brrw Or Lend Disqualified Prsn0BrrwOrLendDisqualifiedPrsnInd
Furn Goods Disqualified Prsn0FurnGoodsDisqualifiedPrsnInd
Pay Comp Disqualified PrsnYes (1)PayCompDisqualifiedPrsnInd
Transfer Ast Disqualified Prsn0TransferAstDisqualifiedPrsnInd
Payment To Government Official0PaymentToGovernmentOfficialInd
Acts Fail To Qlfy As Exceptions0ActsFailToQlfyAsExceptionsInd
Uncorrected Prior Acts0UncorrectedPriorActsInd
Undistributed Income PY0UndistributedIncomePYInd
Business HoldingsYes (1)BusinessHoldingsInd
Excess Business Holdings0ExcessBusinessHoldingsInd
Jeopardy Investments0JeopardyInvestmentsInd
Uncorrected PY Jeopardy Invst0UncorrectedPYJeopardyInvstInd
Influence Legislation0InfluenceLegislationInd
Influence Election0InfluenceElectionInd
Grants To Individuals0GrantsToIndividualsInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Noncharitable Purpose0NoncharitablePurposeInd
Transactions Fail To Qlfy As Exc0TransactionsFailToQlfyAsExcInd
Maintained Expenditure RspnsYes (1)MaintainedExpenditureRspnsInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Subj To Tax Rmnrtn Ex Prcht Pymt0SubjToTaxRmnrtnExPrchtPymtInd

Officer Dir Trst Key Empl Info OfficerDirTrstKeyEmplInfoGrp

Officer Dir Trst Key Empl OfficerDirTrstKeyEmplGrp (7 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdTitleTitleTxtAverage Hrs Per Wk Devoted To PosAverageHrsPerWkDevotedToPosRtCompensationCompensationAmtEmployee Benefit ProgramEmployeeBenefitProgramAmtExpense Account Other AllwncExpenseAccountOtherAllwncAmt
NEIL SMILEY
29 OLD NECK ROADMANCHESTERBYTHESEAMA01944PRESIDENT AND TREASURER1.00$0$0$0
JOHN O PARKER JR
29 OLD NECK ROADMANCHESTERBYTHESEAMA01944VICE PRESIDENT AND CLERK1.00$0$0$0
ROBERT C BOUTWELL
29 OLD NECK ROADMANCHESTERBYTHESEAMA01944TRUSTEE1.00$0$0$0
BARBARA BULA
29 OLD NECK ROADMANCHESTERBYTHESEAMA01944TRUSTEE1.00$0$0$0
BRENDON BULA
29 OLD NECK ROADMANCHESTERBYTHESEAMA01944TRUSTEE1.00$0$0$0
ELIZABETH HOOD
29 OLD NECK ROADMANCHESTERBYTHESEAMA01944TRUSTEE1.00$0$0$0
CLAY SMILEY
29 OLD NECK ROADMANCHESTERBYTHESEAMA01944TRUSTEE1.00$0$0$0
FieldValueIRS element (for citing)
Comp Of Hghst Pd Empl Or NONENONECompOfHghstPdEmplOrNONETxt
Other Employee Paid Over50k0OtherEmployeePaidOver50kCnt

Compensation Of Hghst Pd Cntrct CompensationOfHghstPdCntrctGrp (2 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdService TypeServiceTypeTxtCompensationCompensationAmt
HEALTH RESOURCES IN ACTION
2 BOYLSTON STREET 4TH FLOORBOSTONMA02116ADMINISTRATIVE FEES$244,367
PRIME BUCHHOLZ
273 CORPORATE DRIVE SUITE 250PORTSMOUTHNH03801INVESTMENT ADVISORY SERVICES$78,750
FieldValueIRS element (for citing)
Contractor Paid Over50k0ContractorPaidOver50kCnt

Sum Of Program Related Invst SumOfProgramRelatedInvstGrp

FieldValueIRS element (for citing)
Description1NEOPENDA, PBC - CHICAGO, ILCONVERTIBLE PROMISSORY NOTEDescription1Txt
Expenses1$200,000Expenses1Amt
Description2MOTHER'S MILK IS BEST, INC. - TYNGSBORO, MACONVERTIBLE PROMISSORY NOTEDescription2Txt
Expenses2$200,000Expenses2Amt
All Other Program Rltd Invst Tot$149,995AllOtherProgramRltdInvstTotAmt
Total$549,995TotalAmt

Minimum Investment Return MinimumInvestmentReturnGrp

FieldValueIRS element (for citing)
Average Monthly FMV Of Sec$68,770,835AverageMonthlyFMVOfSecAmt
Average Monthly Cash Balances$8,558,925AverageMonthlyCashBalancesAmt
FMV All Other Noncharitable Ast$17,615,779FMVAllOtherNoncharitableAstAmt
Total FMV Of Unused Assets$94,945,539TotalFMVOfUnusedAssetsAmt
Reduction Claimed$0ReductionClaimedAmt
Acquisition Indebtedness$0AcquisitionIndebtednessAmt
Adjusted Total FMV Of Unused Ast$94,945,539AdjustedTotalFMVOfUnusedAstAmt
Cash Deemed Charitable$1,424,183CashDeemedCharitableAmt
Net Vl Noncharitable Assets$93,521,356NetVlNoncharitableAssetsAmt
Minimum Investment Return$4,676,068MinimumInvestmentReturnAmt

Distributable Amount DistributableAmountGrp

FieldValueIRS element (for citing)
Minimum Investment Return$4,676,068MinimumInvestmentReturnAmt
Tax Based On Investment Income$87,479TaxBasedOnInvestmentIncomeAmt
Total Tax$87,479TotalTaxAmt
Distributable Before Adj$4,588,589DistributableBeforeAdjAmt
Recoveries Qualfied Distri$26,256RecoveriesQualfiedDistriAmt
Distributable Before Ded$4,614,845DistributableBeforeDedAmt
Deduction From Distributable$0DeductionFromDistributableAmt
Distributable As Adjusted$4,614,845DistributableAsAdjustedAmt

PF Qualifying Distributions PFQualifyingDistributionsGrp

FieldValueIRS element (for citing)
Expenses And Contributions$2,915,744ExpensesAndContributionsAmt
Program Related Invst Total$549,995ProgramRelatedInvstTotalAmt
Qualifying Distributions$3,465,739QualifyingDistributionsAmt

Undistributed Income UndistributedIncomeGrp

FieldValueIRS element (for citing)
Distributable As Adjusted$4,614,845DistributableAsAdjustedAmt
Undistributed Income PY$3,268,164UndistributedIncomePYAmt
Total For Prior Years$0TotalForPriorYearsAmt
Total Excess Distribution Cyov$0TotalExcessDistributionCyovAmt
Qualifying Distributions$3,465,739QualifyingDistributionsAmt
Applied To Year1$3,268,164AppliedToYear1Amt
Applied To Prior Years$0AppliedToPriorYearsAmt
Treated As Distri From Corpus$0TreatedAsDistriFromCorpusAmt
Applied To Current Year$197,575AppliedToCurrentYearAmt
Remaining Distri From Corpus$0RemainingDistriFromCorpusAmt
Excess Distri Cyov App CY Corpus$0ExcessDistriCyovAppCYCorpusAmt
Excess Distribution Cyov App CY$0ExcessDistributionCyovAppCYAmt
Total Corpus$0TotalCorpusAmt
Prior Year Undistributed Incm$0PriorYearUndistributedIncmAmt
Prior Year Deficiency Or Tax$0PriorYearDeficiencyOrTaxAmt
Taxable1$0Taxable1Amt
Taxable2$0Taxable2Amt
Undistributed Income CY$4,417,270UndistributedIncomeCYAmt
Corpus Distri170b1 E Or4942g3$0CorpusDistri170b1EOr4942g3Amt
Excess Distri Cyov From Yr5$0ExcessDistriCyovFromYr5Amt
Excess Distri Cyov To Next Yr$0ExcessDistriCyovToNextYrAmt

Supplementary Information SupplementaryInformationGrp

Application Submission Info ApplicationSubmissionInfoGrp

FieldValueIRS element (for citing)
Recipient PersonCHARLENE MANCUSI DIRECTOR HRIARecipientPersonNm

Recipient US Address RecipientUSAddress

FieldValueIRS element (for citing)
Address Line129 OLD NECK ROADAddressLine1Txt
CityMANCHESTERBYTHESEACityNm
State AbbreviationMAStateAbbreviationCd
ZIP01944ZIPCd
FieldValueIRS element (for citing)
Recipient Phone6176959439RecipientPhoneNum
Recipient Email AddressCMANCUSI@HRIA.ORGRecipientEmailAddressTxt
Form And Info And MaterialsAPPLICATION FORMS AVAILABLE AT WWW.TMFGRANTS.ORG/HOODFormAndInfoAndMaterialsTxt
Submission DeadlinesANNUALLY MARCH AND OCTOBERSubmissionDeadlinesTxt
Restrictions On AwardsRESTRICTED TO PEDIATRIC RESEARCHRestrictionsOnAwardsTxt

Grant Or Contribution Pd Dur Yr GrantOrContributionPdDurYrGrp (22 entries)

Address Line1RecipientUSAddress/AddressLine1TxtCityRecipientUSAddress/CityNmState AbbreviationRecipientUSAddress/StateAbbreviationCdZIPRecipientUSAddress/ZIPCdRecipient Foundation StatusRecipientFoundationStatusTxtGrant Or Contribution PurposeGrantOrContributionPurposeTxtAmtAmtAddress Line2RecipientUSAddress/AddressLine2Txt
YALE UNIVERSITY
C/O BANK OF AMERICANEW HAVENCT065208239PCCHILD HEALTH RESEARCH AWARD - SUPPORTING REFUGEE MENTAL HEALTH THROUGH TRANSLATION OF EVALUATIVE INSTRUMENTS AND THROUGH A PREVENTIVE MENTAL HEALTH INTERVENTION$100,000
MASSACHUSETTS GENERAL HOSPITAL
BANK OF AMERICA NA PO BOX 414876BOSTONMA022414876PCCHILD HEALTH RESEARCH AWARD - TACKLING PULMONARY HYPOPLASIA WITH GENETIC, EPIGENETIC AND STEM CELL APPROACHES.$100,000
BOSTON COLLEGE
BANK OF AMERICA 222 BROADWAY STNEW YORKNY10038PCCHILD HEALTH RESEARCH AWARD - IMPROVING CHILDHOOD TUBERCULOSIS TREATMENT OUTCOMES AND POST-TB LUNG FUNCTIONING AND QUALITY OF LIFE IN RURAL SOUTH AFRICA$100,000
BOSTON CHILDREN'S HOSPITAL
C/O BANK OF AMERICA 100 FEDERALBOSTONMA02110PCCHILD HEALTH RESEARCH AWARD - IDENTIFYING EEG-BASED BIOMARKERS OF LANGUAGE GROWTH IN PRESCHOOL-AGED CHILDREN WITH DOWN SYNDROME$100,000STREET
BOSTON CHILDREN'S HOSPITAL
C/O BANK OF AMERICA 100 FEDERALBOSTONMA02110PCCHILD HEALTH RESEARCH AWARD - CHARACTERIZING THE ROLE OF TWO SUBCORTICAL NUCLEI IN PREFRONTAL REGULATION OF ATTENTION$100,000STREET
BOSTON CHILDREN'S HOSPITAL
C/O BANK OF AMERICA 100 FEDERALBOSTONMA02110PCCHILD HEALTH RESEARCH AWARD - POSTNATAL EXPOSURE TO HYPEROXIA CAUSES MALADAPTATION OF THE PREMATURE INTESTINE$100,000STREET
BOSTON CHILDREN'S HOSPITAL
C/O BANK OF AMERICA 100 FEDERALBOSTONMA02110PCCHILD HEALTH RESEARCH AWARD - ROLE OF XENOBIOTIC PATHWAYS TO MODULATE INTESTINAL EPITHELIAL METABOLISM, AS POSSIBLE TARGETS FOR OBESITY AND DIABETES$100,000STREET
BRIGHAM AND WOMEN'S HOSPITAL
C/O BANK OF AMERICA 100 FEDERALBOSTONMA02110PCCHILD HEALTH RESEARCH AWARD - THE ROLE OF MESENCHYMAL STEM CELLS TO ENHANCE IMMUNE FUNCTION IN A MODEL OF NEONATAL INFECTION$100,000STREET
DARTMOUTH-HITCHCOCK CLINIC
RESEARCH OPERATIONS 1 MEDICALLEBANONNH03756PCCHILD HEALTH RESEARCH AWARD - EVALUATING MECHANISMS OF ENVIRONMENTAL CHEMICAL EXPOSURE WITH DEVELOPING ZEBRAFISH URINARY SYSTEM$70,000CENTER DRIVE
MASSACHUSETTS EYE AND EAR INFIRMARY
C/O BANK OF AMERICA 100 FEDERALBOSTONMA02110PCCHILD HEALTH RESEARCH AWARD - ADVANCING THE RETINOIC ACID SIGNALING ACTIVATOR AS A NOVEL THERAPEUTIC IN MOUSE MODELS OF RETINAL DEGENERATION$100,000STREET
MASSACHUSETTS GENERAL HOSPITAL
C/O BANK OF AMERICA 100 FEDERALBOSTONMA02110PCCHILD HEALTH RESEARCH AWARD - DECIPHERING THE MECHANISM UNDERLYING SHORT- AND LONG-TERM AIRWAY HYPERRESPONSIVENESS FOLLOWING EARLY-LIFE RSV INFECTION$100,000STREET
MASSACHUSETTS GENERAL HOSPITAL
C/O BANK OF AMERICA 100 FEDERALBOSTONMA02110PCCHILD HEALTH RESEARCH AWARD - EVALUATING EFFECTIVE COMBINATIONS OF MODIFIABLE FACTORS FOR PREVENTING YOUTH DEPRESSION RISK$100,000STREET
HARVARD UNIVERSITY
C/O BANK OF AMERICA 100 FEDERALBOSTONMA02110PCCHILD HEALTH RESEARCH AWARD - TARGETING LIPID DYSREGULATION IN HEREDITARY SPASTIC PARAPLEGIA$100,000STREET
YALE UNIVERSITY
C/O BANK OF AMERICANEW HAVENCT065208239PCCHILD HEALTH RESEARCH AWARD - IMPACT OF EARLY LIFE IMMUNE CHALLENGES ON BRAIN WIRING$100,000
MASSACHUSETTS EYE AND EAR INFIRMARY
C/O BANK OF AMERICA 100 FEDERALBOSTONMA02110PCCHILD HEALTH RESEARCH AWARD - CHARACTERIZATION OF SENSORINEURAL HEARING LOSS IN NEUROFIBROMATOSIS TYPE 2$100,000STREET
BOSTON CHILDREN'S HOSPITAL
C/O BANK OF AMERICA 100 FEDERALBOSTONMA02110PCCHILD HEALTH RESEARCH AWARD - NANOBODY-BASED IMMUNOTHERAPY FOR MODULATING INFLAMMATION IN JUVENILE IDIOPATHIC ARTHRITIS$100,000STREET
DANA-FARBER CANCER INSTITUTE
C/O BANK OF AMERICA 100 FEDERALBOSTONMA02110PCCHILD HEALTH RESEARCH AWARD - TARGETING CHROMATIN REGULATORS IN NUP98-REARRANGED ACUTE MYELOID LEUKEMIA$100,000STREET
HARVARD PILGRIM HEALTH CARE
C/O BANK OF AMERICA 100 FEDERALBOSTONMA02110PCCHILD HEALTH RESEARCH AWARD - SOCIOECONOMIC INEQUITIES IN RSV IMMUNIZATION AND POPULATION-BASED OUTCOMES$100,000STREET
BOSTON CHILDREN'S HOSPITAL
C/O BANK OF AMERICA 100 FEDERALBOSTONMA02110PCCHILD HEALTH RESEARCH AWARD - UNDERSTANDING MECHANISMS FOR IMPROVED PEDIATRIC SKELETAL HEALTH: NOVEL REGULATORS OF CHONDROCYTE-TO-OSTEOBLAST TRANSDIFFERENTIATION$100,000STREET
BOSTON UNIVERSITY
C/O JPMORGAN CHASE 270 PARK AVENEW YORKNY10017PCCHILD HEALTH RESEARCH AWARD - HISTONE MARKS PROFILING: DECODING CELLULAR MECHANISMS IN CONGENITAL RARE DISORDERS CAUSED BY PATHOGENIC VARIANTS IN CHROMATIN-MODIFIER GENES$100,000
MASSACHUSETTS GENERAL HOSPITAL
C/O BANK OF AMERICA 100 FEDERALBOSTONMA02110PCCHILD HEALTH RESEARCH AWARD - EPIGENETIC REGULATION OF NEURAL EXCITABILITY IN A MOUSE MODEL OF INFANTILE EPILEPSY$100,000STREET
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
C/O BANK OF AMERICA 100 FEDERALBOSTONMA02110PCHOOD PEDIATRIC INNOVATION HUB$400,000STREET
FieldValueIRS element (for citing)
Total Grant Or Contri Pd Dur Yr$2,470,000TotalGrantOrContriPdDurYrAmt

Grant Or Contri Apprv For Fut GrantOrContriApprvForFutGrp (11 entries)

Address Line1RecipientUSAddress/AddressLine1TxtAddress Line2RecipientUSAddress/AddressLine2TxtCityRecipientUSAddress/CityNmState AbbreviationRecipientUSAddress/StateAbbreviationCdZIPRecipientUSAddress/ZIPCdRecipient Foundation StatusRecipientFoundationStatusTxtGrant Or Contribution PurposeGrantOrContributionPurposeTxtAmtAmt
MASSACHUSETTS GENERAL HOSPITAL
C/O BANK OF AMERICA 100 FEDERALSTREETBOSTONMA02110PCCHILD HEALTH RESEARCH AWARD - EVALUATING EFFECTIVE COMBINATIONS OF MODIFIABLE FACTORS FOR PREVENTING YOUTH DEPRESSION RISK$100,000
HARVARD UNIVERSITY
C/O BANK OF AMERICA 100 FEDERALSTREETBOSTONMA02110PCCHILD HEALTH RESEARCH AWARD - TARGETING LIPID DYSREGULATION IN HEREDITARY SPASTIC PARAPLEGIA$100,000
YALE UNIVERSITY
C/O BANK OF AMERICANEW HAVENCT065208239PCCHILD HEALTH RESEARCH AWARD - IMPACT OF EARLY LIFE IMMUNE CHALLENGES ON BRAIN WIRING$100,000
MASSACHUSETTS EYE AND EAR INFIRMARY
C/O BANK OF AMERICA 100 FEDERALSTREETBOSTONMA02110PCCHILD HEALTH RESEARCH AWARD - CHARACTERIZATION OF SENSORINEURAL HEARING LOSS IN NEUROFIBROMATOSIS TYPE 2$100,000
BOSTON CHILDREN'S HOSPITAL
C/O BANK OF AMERICA 100 FEDERALSTREETBOSTONMA02110PCCHILD HEALTH RESEARCH AWARD - NANOBODY-BASED IMMUNOTHERAPY FOR MODULATING INFLAMMATION IN JUVENILE IDIOPATHIC ARTHRITIS$100,000
DANA-FARBER CANCER INSTITUTE
C/O BANK OF AMERICA 100 FEDERALSTREETBOSTONMA02110PCCHILD HEALTH RESEARCH AWARD - TARGETING CHROMATIN REGULATORS IN NUP98-REARRANGED ACUTE MYELOID LEUKEMIA$100,000
HARVARD PILGRIM HEALTH CARE
C/O BANK OF AMERICA 100 FEDERALSTREETBOSTONMA02110PCCHILD HEALTH RESEARCH AWARD - SOCIOECONOMIC INEQUITIES IN RSV IMMUNIZATION AND POPULATION-BASED OUTCOMES$100,000
BOSTON CHILDREN'S HOSPITAL
C/O BANK OF AMERICA 100 FEDERALSTREETBOSTONMA02110PCCHILD HEALTH RESEARCH AWARD - UNDERSTANDING MECHANISMS FOR IMPROVED PEDIATRIC SKELETAL HEALTH: NOVEL REGULATORS OF CHONDROCYTE-TO-OSTEOBLAST TRANSDIFFERENTIATION$100,000
BOSTON UNIVERSITY
C/O JPMORGAN CHASE 270 PARK AVENEW YORKNY10017PCCHILD HEALTH RESEARCH AWARD - HISTONE MARKS PROFILING: DECODING CELLULAR MECHANISMS IN CONGENITAL RARE DISORDERS CAUSED BY PATHOGENIC VARIANTS IN CHROMATIN-MODIFIER GENES$100,000
MASSACHUSETTS GENERAL HOSPITAL
C/O BANK OF AMERICA 100 FEDERALSTREETBOSTONMA02110PCCHILD HEALTH RESEARCH AWARD - EPIGENETIC REGULATION OF NEURAL EXCITABILITY IN A MOUSE MODEL OF INFANTILE EPILEPSY$100,000
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
C/O BANK OF AMERICA 100 FEDERALSTREETBOSTONMA02110PCHOOD PEDIATRIC INNOVATION HUB$4,600,000
FieldValueIRS element (for citing)
Total Grant Or Contri Apprv Fut$5,600,000TotalGrantOrContriApprvFutAmt

Analysis Income Producing Acty AnalysisIncomeProducingActyGrp

Dividends And Interest From Sec Dtl DividendsAndInterestFromSecDtl

FieldValueIRS element (for citing)
Exclusion14ExclusionCd
Exclusion$2,066,610ExclusionAmt

Gain Sales Ast Oth Than Invntry GainSalesAstOthThanInvntryGrp

FieldValueIRS element (for citing)
Exclusion18ExclusionCd
Exclusion$4,246,783ExclusionAmt

Other Revenue Described OtherRevenueDescribedGrp (3 entries)

DescDescExclusionExclusionCdExclusionExclusionAmtRelated Or Exempt Function IncmRelatedOrExemptFunctionIncmAmt
INCOME FROM ALTERNATIVE INVESTMENTS18$181,544
RETURNED GRANTS$26,256
OTHER INVESTMENT INCOME$882

Subtotals Incm Producing Acty SubtotalsIncmProducingActyGrp

FieldValueIRS element (for citing)
Unrelated Business Taxbl Incm$0UnrelatedBusinessTaxblIncmAmt
Exclusion$6,494,937ExclusionAmt
Related Or Exempt Function Incm$27,138RelatedOrExemptFunctionIncmAmt
FieldValueIRS element (for citing)
Total Income Producing Acty$6,522,075TotalIncomeProducingActyAmt

Rln Of Acty To Accom Of Exmpt Prps RlnOfActyToAccomOfExmptPrpsGrp

Rln Of Acty To Accom Of Exmpt Prps RlnOfActyToAccomOfExmptPrpsGrp (2 entries)

Line NumberLineNumberTxtRelationship StatementRelationshipStatementTxt
11CEXCESS FUNDS RETURNED FROM GRANTS PREVIOUSLY PAID OUT.
11DSETTLEMENT PROCEEDS ON INVESTMENTS

Trnsfr Trans Rln Nonchrtbl EO TrnsfrTransRlnNonchrtblEOGrp

FieldValueIRS element (for citing)
Trnsfr Of Cash To Nonchrtbl EO0TrnsfrOfCashToNonchrtblEOInd
Trnsfr Other Asset Nonchrtbl EO0TrnsfrOtherAssetNonchrtblEOInd
Sales Or Exchanges Of Assets0SalesOrExchangesOfAssetsInd
Purchase Of Assets Nonchrtbl EO0PurchaseOfAssetsNonchrtblEOInd
Rental Of Facilities Oth Assets0RentalOfFacilitiesOthAssetsInd
Reimbursement Arrangements0ReimbursementArrangementsInd
Loans Or Loan Guarantees0LoansOrLoanGuaranteesInd
Performance Of Services Etc0PerformanceOfServicesEtcInd
Sharing Of Facilities Etc0SharingOfFacilitiesEtcInd
Relationships Nonchrtbl EO0RelationshipsNonchrtblEOInd

Schedule B IRS990ScheduleB

FieldValueIRS element (for citing)
Organization501c3 Exempt PFYes (X)Organization501c3ExemptPFInd
General RuleYes (X)GeneralRuleInd

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
Contributor1ContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1ESTATE OF JUDITH HOODBusinessNameLine1Txt

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1BANK OF AMERICA 1025 MAIN STAddressLine1Txt
CityWALTHAMCityNm
State AbbreviationMAStateAbbreviationCd
ZIP02451ZIPCd
FieldValueIRS element (for citing)
Total Contributions$21,668,457TotalContributionsAmt
Person ContributionYes (X)PersonContributionInd

Accounting Fees Schedule AccountingFeesSchedule

Accounting Fees Detail AccountingFeesDetail

FieldValueIRS element (for citing)
CategoryACCOUNTING & TAX PREPARATION FEESCategoryTxt
Amt$29,863Amt
Net Investment Income$0NetInvestmentIncomeAmt
Disbursements Charitable Prps$29,863DisbursementsCharitablePrpsAmt

All Oth Prog Rltd Investments Sch AllOthProgRltdInvestmentsSch

All Other Program Related Invst AllOtherProgramRelatedInvstGrp (2 entries)

DescDescAmtAmt
ARGUS COGNITIVE, INC. - LEBANON, NH SIMPLE AGREEMENT FOR FUTURE EQUITY$49,995
MULBERRY THERAPEUTICS - WELLESLEY, MA CONVERTIBLE PROMISSORY NOTE$100,000

Expenditure Responsibility Stmt ExpenditureResponsibilityStmt

Expenditure Responsibility ExpenditureResponsibilityGrp (28 entries)

Address Line1USAddress/AddressLine1TxtAddress Line2USAddress/AddressLine2TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdGrantGrantDtGrantGrantAmtPurpose Of GrantPurposeOfGrantTxtExpended By GranteeExpendedByGranteeAmtAny Diversion By GranteeAnyDiversionByGranteeTxtDates Of Reports By GranteeDatesOfReportsByGranteeTxtVerificationVerificationDtResults Of VerificationResultsOfVerificationTxtAddress Line1ForeignAddress/AddressLine1TxtCityForeignAddress/CityNmProvince Or StateForeignAddress/ProvinceOrStateNmCountryForeignAddress/CountryCdForeign PostalForeignAddress/ForeignPostalCd
ALDATU BIOSCIENCES INC
C/O ARSENAL LAB SPACE 201 DEXTERAVEWATERTOWNMA024722016-02-23$100,000TO SUPPORT THE USE AND DEVELOPMENT OF A SIMPLE, RAPID, THERMOSTABLE KIT THAT IDENTIFIES CLINICALLY ACTIONABLE HIV MUTATIONS FOUND IN PATIENTS FAILING A FIRST-LINE DRUG REGIMEN, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE AND RELIEF OF THE POOR, DISTRESSED AND UNDERPRIVILEGED.$100,000NONE, SEE BELOWPRI REPORTS - 6/12/2024, 6/27/20252017-12-15THE TRUSTEES MEET WITH ALDATU BIOSCIENCES, INC. MANAGEMENT ON A REGULAR BASIS AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY.
ANIDA PHARMA INC
155 BROOKLINE STREET SUITE 005CAMBRIDGEMA021392020-12-21$250,000TO SUPPORT THE PRECLINICAL DEVELOPMENT OF A PREVENTATIVE TREATMENT FOR RETINOPATHY OF PREMATURITY, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE AND RELIEF OF THE POOR, DISTRESSED AND UNDERPRIVILEGED.$250,000NONE, SEE BELOWPRI REPORTS - 6/24/2024, 1/3/2025, 6/17/20252023-07-21THE TRUSTEES MEET WITH ANIDA PHARMA, INC. MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
ARGUS COGNITIVE INC
DARTMOUTH REGIONAL TECHNICAL CTR 16CAVENDISH CTLEBANONNH037662021-05-10$250,000TO SUPPORT THE DEVELOPMENT AND CLINICAL TESTING OF THE CORPORATION'S CLINICAL DECISION SUPPORT SOFTWARE FOR USE IN PEDIATRIC INDICATIONS, INCLUDING AUTISM AND PEDIATRIC CARDIOLOGY, THEREBY SUPPORTING RELIEF OF THE POOR, DISTRESSED AND UNDERPRIVILEGED AND LESSENING THE BURDEN OF THE GOVERNMENT.$250,000NONE, SEE BELOWPRI REPORTS - 3/5/2024,5/18/2024, 6/6/2024, 7/3/2024, 7/26/2024, 9/9/2024, 92023-08-23THE TRUSTEES MEET WITH ARGUS COGNITIVE, INC. MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
ARGUS COGNITIVE INC
DARTMOUTH REGIONAL TECHNICAL CTR 16CAVENDISH CTLEBANONNH037662023-07-10$25,000TO SUPPORT THE DEVELOPMENT AND CLINICAL TESTING OF THE CORPORATION'S CLINICAL DECISION SUPPORT SOFTWARE FOR USE IN PEDIATRIC INDICATIONS, INCLUDING AUTISM AND PEDIATRIC CARDIOLOGY, THEREBY SUPPORTING RELIEF OF THE POOR, DISTRESSED AND UNDERPRIVILEGED AND LESSENING THE BURDEN OF THE GOVERNMENT.$25,000NONE, SEE BELOWPRI REPORTS - 3/5/2024,5/18/2024, 6/6/2024, 7/3/2024, 7/26/2024, 9/9/2024, 92024-09-13THE TRUSTEES MEET WITH ARGUS COGNITIVE, INC. MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
ARGUS COGNITIVE INC
DARTMOUTH REGIONAL TECHNICAL CTR 16CAVENDISH CTLEBANONNH037662024-06-24$49,995TO SUPPORT THE DEVELOPMENT AND CLINICAL TESTING OF THE CORPORATION'S CLINICAL DECISION SUPPORT SOFTWARE FOR USE IN PEDIATRIC INDICATIONS, INCLUDING AUTISM AND PEDIATRIC CARDIOLOGY, THEREBY SUPPORTING RELIEF OF THE POOR, DISTRESSED AND UNDERPRIVILEGED AND LESSENING THE BURDEN OF THE GOVERNMENT.$49,995NONE, SEE BELOWPRI REPORTS - 3/5/2024,5/18/2024, 6/6/2024, 7/3/2024, 7/26/2024, 9/9/2024, 92025-09-04THE TRUSTEES MEET WITH ARGUS COGNITIVE, INC. MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
BIOROSA TECHNOLOGIES INC
63 BAKER STREETBELMONTMA024782020-07-15$150,000TO SUPPORT THE DEVELOPMENT OF A BLOOD-BASED STANDARD-OF-CARE DIAGNOSTIC FOR AUTISM SPECTRUM DISORDERS ("ASD") THAT IS INTENDED TO LEAD TO EARLIER DETECTION OF ASD THAN IS CURRENTLY AVAILABLE, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE AND LESSENING THE BURDEN OF THE GOVERNMENT.$150,000NONE, SEE BELOWPRI REPORTS - 1/8/2024, 9/24/2024, 9/3/20252021-07-16THE TRUSTEES MEET WITH BIOROSA TECHNOLOGIES, INC. MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
BIOROSA TECHNOLOGIES INC
63 BAKER STREETBELMONTMA024782022-11-15$100,000TO SUPPORT THE DEVELOPMENT OF A BLOOD-BASED STANDARD-OF-CARE DIAGNOSTIC FOR AUTISM SPECTRUM DISORDERS ("ASD") THAT IS INTENDED TO LEAD TO EARLIER DETECTION OF ASD THAN IS CURRENTLY AVAILABLE, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE AND LESSENING THE BURDEN OF THE GOVERNMENT.$100,000NONE, SEE BELOWPRI REPORTS - 1/8/2024, 9/24/2024, 9/3/20252023-08-14THE TRUSTEES MEET WITH BIOROSA TECHNOLOGIES, INC. MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
BREEGI SCIENTIFIC INC
120 BEDFORD ROADWOBURNMA018012017-06-26$250,000THE FUNDS WILL BE USED TO CONDUCT A THOROUGH CLINICAL ASSESSMENT OF BSI'S NOVEL NEONATAL INTENSIVE CARE INCUBATOR "(NICI)" IN HONDURAS AND ZAMBIA AND TO AID THE COMMERCIALIZATION EFFORTS OF THIS LIFE-SAVING MEDICAL DEVICE, THEREBY LESSENING THE BURDEN OF THE GOVERNMENT AND RELIEF OF THE POOR, DISTRESSED AND UNDERPRIVILEGED.$250,000NONE, SEE BELOWPRI REPORTS - 6/3/2024, 10/1/2024, 9/26/20252021-08-02THE TRUSTEES MEET WITH BREEGI SCIENTIFIC, INC. MANAGEMENT ON A REGULAR BASIS AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
DECK THERAPEUTICS INC
8 HARVARD LANEHASTINGS ON HUDSONNY107062022-10-12$200,000TO SUPPORT THE DEVELOPMENT OF SEMI-SYNTHETIC OMEGA-3 COMPOUNDS THAT BLOCK MULTIPLE CELL-DEATH PATHWAYS INDUCED BY HYPOXIC-ISCHEMIC INJURY IN NEONATES.$200,000NONE, SEE BELOWPRI REPORTS - 6/26/2024, 2/4/2025, 7/4/20252023-05-02THE TRUSTEES MEET WITH DECK THERAPEUTICS, INC. MANAGEMENT ON A REGULAR BASIS AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
INKSPACE IMAGING INC
5635 W LAS POSITAS BLVD STE 403/404PLEASANTONCA945882022-10-20$250,000TO SUPPORT THE DEVELOPMENT OF FLEXIBLE, LIGHTWEIGHT, LOW COST MRI COILS DESIGNED SPECIFICALLY FOR PEDIATRIC PATIENTS, WHILE ALSO IMPROVING IMAGE RESOLUTION AND REDUCING MRI FAILURE RATES.$250,000NONE, SEE BELOWPRI REPORTS - 8/12/2024, 7/2/2025, 9/8/20252024-08-12THE TRUSTEES MEET WITH INKSPACE IMAGING, INC. MANAGEMENT ON A REGULAR BASIS AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
MESENTECH INC
2020-11-02$250,000TO SUPPORT THE ADVANCEMENT OF SCIENCE AND PROMOTION OF HEALTH THROUGH THE PRECLINICAL RESEARCH OF ANABOLIC BONE THERAPEUTICS THAT CAN INCREASE BONE MASS TO STRENGTHEN THE SKELETON AND THE DEVELOPMENT OF A DRUG DELIVERY SYSTEM TO BE INITIALLY APPLIED TO TWO PEDIATRIC RARE DISEASES: OSTEOGENESIS IMPERFECTA AND DUCHENNE MUSCULAR DYSTROPHY.$250,000NONE, SEE BELOWPRI REPORTS - 6/4/2024, 6/5/2024, 11/19/2024, 3/6/2025, 5/20/20252022-08-26THE TRUSTEES MEET WITH MESENTECH, INC. MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY2222 HEALTH SCIENCES RDVANCOUVERBRITISH COLUMBIACAV6T2B9
MOTHERS MILK IS BEST INC
1510 LAKESIDE AVENUEFORT COLLINSCO805212024-12-27$200,000TO SUPPORT THE CONDUCTING OF SCIENTIFIC RESEARCH RELATED TO THE DEVELOPMENT OF A MEDICAL DEVICE THAT CONCENTRATES HUMAN MILK TO PROVIDE LOW VOLUME, HIGH NUTRIENT FEEDINGS PRESCRIBED FOR PRETERM INFANTS.$0NONE, SEE BELOWPRI REPORT - 4/1/2025, 5/23/20252025-05-23THE TRUSTEES MEET WITH MOTHERS MILK IS BEST, INC. MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
MULBERRY BIOTHERAPEUTICS INC
40 WALNUT STREET SUITE 301WELLESLEYMA024812023-12-26$250,000TO SUPPORT PRECLINICAL WORK RELATING TO THE DEVELOPMENT OF A BACTERIA-MEDIATED THERAPY FOR NEUROFIBROMATOSIS TYPE 2.$222,101NONE, SEE BELOWPRI REPORT - 6/11/2024, 12/16/2024, 6/19/20252025-06-19THE TRUSTEES MEET WITH MULBERRY BIOTHERAPEUTICS INC. MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
MULBERRY BIOTHERAPEUTICS INC
40 WALNUT STREET SUITE 301WELLESLEYMA024812024-12-20$100,000TO SUPPORT PRECLINICAL WORK RELATING TO THE DEVELOPMENT OF A BACTERIA-MEDIATED THERAPY FOR NEUROFIBROMATOSIS TYPE 2.$0NONE, SEE BELOWPRI REPORT - 6/11/2024, 12/16/2024, 6/19/20252025-06-19THE TRUSTEES MEET WITH MULBERRY BIOTHERAPEUTICS INC. MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
NEOPENDA PBC
1623 W FULTON STCHICAGOIL606122024-11-15$200,000TO SUPPORT THE CONDUCTING OF SCIENTIFIC RESEARCH IN THE PUBLIC INTEREST RELATED TO THE DEVELOPMENT OF AFFORDABLE, LIFE-SAVING MEDICAL DEVICES TAILORED FOR LOW-RESOURCE SETTINGS SUCH AS KENYA AND EAST AFRICA.$172,110NONE, SEE BELOWPRI REPORT - 2/7/2025, 9/8/20252025-09-08THE TRUSTEES MEET WITH NEOPENDA, PBC MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
NICOLETTE INC
100 W BROADWAY SUITE 3000LONG BEACHCA908022021-12-23$200,000TO DEVELOP AND TEST A TABLET-BASED APPLICATION THAT TRANSLATES DATA PULLED FROM A BABY'S ELECTRONIC MEDICAL RECORD INTO EASILY UNDERSTOOD, SIMPLE SENTENCES COMPLEMENTED BY VISUAL AIDS, SUCH AS GRAPHS AND CHARTS, FOR THE BENEFIT OF THE PUBLIC, INCLUDING PARENTS, IN AN ATTEMPT TO CHANGE THE STANDARD OF CARE BY IMPROVING LIVES, REDUCING MEDICAL ERRORS, AND REDUCING OVERALL HEALTHCARE COSTS.$200,000NONE, SEE BELOWPRI REPORT - 4/10/2024, 6/17/2024, 10/15/2025, 4/16/2025, 6/16/20252024-06-17THE TRUSTEES MEET WITH NICOLETTE, INC. MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
NONINVASIX INC
1700 THE STRAND SUITE 1200GALVESTONTX775552015-12-30$150,000TO SUPPORT THE USE AND DEVELOPMENT OF THE COMPANY'S PEDIATRIC BRAIN OXYGENATION MONITORING SYSTEM, WHICH HAS THE POTENTIAL TO MORE ACCURATELY ASSESS THE RISK OF BRAIN HYPOXIA IN FETUSES AND NEONATES, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE AND LESSENING THE BURDEN OF THE GOVERNMENT.$150,000NONE, SEE BELOWPRI REPORTS - 5/31/2024, 1/24/2025, 7/23/20252017-12-15THE TRUSTEES MEET WITH NONINVASIX, INC. MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
NONINVASIX INC
1700 THE STRAND SUITE 1200GALVESTONTX775552016-07-27$150,000TO SUPPORT THE USE AND DEVELOPMENT OF THE COMPANY'S PEDIATRIC BRAIN OXYGENATION MONITORING SYSTEM, WHICH HAS THE POTENTIAL TO MORE ACCURATELY ASSESS THE RISK OF BRAIN HYPOXIA IN FETUSES AND NEONATES, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE AND LESSENING THE BURDEN OF THE GOVERNMENT.$150,000NONE, SEE BELOWPRI REPORTS - 5/31/2024, 1/24/2025, 7/23/20252017-12-15THE TRUSTEES MEET WITH NONINVASIX, INC. MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
NONINVASIX INC
1700 THE STRAND SUITE 1200GALVESTONTX775552017-07-27$7,000TO SUPPORT THE USE AND DEVELOPMENT OF THE COMPANY'S PEDIATRIC BRAIN OXYGENATION MONITORING SYSTEM, WHICH HAS THE POTENTIAL TO MORE ACCURATELY ASSESS THE RISK OF BRAIN HYPOXIA IN FETUSES AND NEONATES, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE AND LESSENING THE BURDEN OF THE GOVERNMENT.$7,000NONE, SEE BELOWPRI REPORTS - 5/31/2024, 1/24/2025, 7/23/20252017-12-15THE TRUSTEES MEET WITH NONINVASIX, INC. MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
NOVONATE INC
395 OYSTER POINT BLVD SUITE 501SOUTH SAN FRANCISCOCA940802022-08-03$150,000TO SUPPORT THE PERFORMANCE OF SCIENTIFIC RESEARCH TO BENEFIT THE PUBLIC BY DEVELOPING MEDICAL DEVICES FOR PATIENTS IN THE NEONATAL INTENSIVE CARE UNIT.$150,000NONE, SEE BELOWPRI REPORTS - 7/25/2023, 7/27/20232023-07-27NOVONATE WAS ACQUIRED IN 2023 AND THE $150,000 WAS REPAID TO THE FOUNDATION. PRIOR TO THIS, THE TRUSTEES MET WITH NOVONATE, INC. MANAGEMENT ON A REGULAR BASIS AND REVIEWED THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
NURTURE GENOMICS
CAMBRIDGE INNOVATION CTR ONEBROADWAY KENDALL SQUARECAMBRIDGEMA021422023-12-26$250,000TO SUPPORT THE PRE-COMMERCIAL AND PILOT DEVELOPMENT OF A SCREENING AND TELEHEALTH PLATFORM TO PROVIDE GENETIC INSIGHTS THAT HELP PARENTS AND THEIR MEDICAL PROVIDERS BETTER UNDERSTAND RISKS FROM CHILDBIRTH INTO ADOLESCENCE.$250,000NONE, SEE BELOWPRI REPORT - 6/23/2024, 7/25/2025, 8/12/20252025-08-12THE TRUSTEES MEET WITH NURTURE GENOMICS MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
PLAKOUS THERAPEUTICS
755 HIGHLAND OAKS DR SUITE 103WINSTONSALEMNC271032023-07-03$250,000TO SUPPORT THE PRECLINICAL DEVELOPMENT OF A BIOLOGIC TO TREAT BABIES DIAGNOSED OR AT RISK OF DEVELOPING NECROTIZING ENTEROCOLITIS (NEC).$250,000NONE, SEE BELOWPRI REPORTS - 2/2/2024, 6/6/2024, 5/20/20252024-02-02THE TRUSTEES MEET WITH PLAKOUS THERAPEUTICS MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
PRAPELA LLC
2 MAIN STREETBIDDEFORDME040052018-07-02$250,000TO SUPPORT THE DEVELOPMENT OF THE COMPANY'S SLEEP TECHNOLOGY PRODUCTS FOR IMPROVING THE HEALTH OF INFANTS WHO COULD BENEFIT FROM WITHDRAWAL TREATMENT AND POST-WITHDRAWAL SUPPORT OF NEONATAL ABSTINENCE SYNDROME ("NAS") A CONDITION CAUSED BY THE PRENATAL USE OF OPIOIDS OR OTHER DRUGS BY PREGNANT WOMEN, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE, LESSENING THE BURDEN OF THE GOVERNMENT, AND RELIEF OF THE POOR, DISTRESSED AND UNDERPRIVILEGED.$250,000NONE, SEE BELOWPRI REPORTS - 6/17/2024, 9/24/2024, 2/1/2025, 4/1/2025, 9/4/20252020-09-10THE TRUSTEES MEET WITH PRAPELA, LLC MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY.
PRAPELA LLC
2 MAIN STREETBIDDEFORDME040052023-12-20$50,000TO SUPPORT THE DEVELOPMENT OF THE COMPANY'S SLEEP TECHNOLOGY PRODUCTS FOR IMPROVING THE HEALTH OF INFANTS WHO COULD BENEFIT FROM WITHDRAWAL TREATMENT AND POST-WITHDRAWAL SUPPORT OF NEONATAL ABSTINENCE SYNDROME ("NAS") A CONDITION CAUSED BY THE PRENATAL USE OF OPIOIDS OR OTHER DRUGS BY PREGNANT WOMEN, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE, LESSENING THE BURDEN OF THE GOVERNMENT, AND RELIEF OF THE POOR, DISTRESSED AND UNDERPRIVILEGED.$42,700NONE, SEE BELOWPRI REPORTS - 6/17/2024, 9/24/2024, 2/1/2025, 4/1/2025, 9/4/20252025-09-04THE TRUSTEES MEET WITH PRAPELA, LLC MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY.
SMOLTAP INC
150 CHESTNUT STREET SUITE CPROVIDENCERI029032022-07-25$99,997TO SUPPORT THE PERFORMANCE OF SCIENTIFIC RESEARCH TO DEVELOP A NOVEL DEVICE WHICH HOLDS AN INFANT STABLE DURING THE LUMBER PUNCTURE PROCEDURE WHEN ADMINISTERING A SPINAL TAP TO DIAGNOSE MENINGITIS IN IN FEBRILE INFANTS UP TO FOUR WEEKS OLD.$99,997NONE, SEE BELOWPRI REPORTS - 5/30/2024, 9/3/2024, 4/23/2025, 5/9/2025, 5/28/20252023-05-30THE TRUSTEES MEET WITH SMOLTAP, INC. MANAGEMENT ON A REGULAR BASIS AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
SMOLTAP INC
150 CHESTNUT STREET SUITE CPROVIDENCERI029032023-09-11$100,000TO SUPPORT THE PERFORMANCE OF SCIENTIFIC RESEARCH TO DEVELOP A NOVEL DEVICE WHICH HOLDS AN INFANT STABLE DURING THE LUMBER PUNCTURE PROCEDURE WHEN ADMINISTERING A SPINAL TAP TO DIAGNOSE MENINGITIS IN IN FEBRILE INFANTS UP TO FOUR WEEKS OLD.$100,000NONE, SEE BELOWPRI REPORTS - 5/30/2024, 9/3/2024, 4/23/2025, 5/9/2025, 5/28/20252025-05-28THE TRUSTEES MEET WITH SMOLTAP, INC. MANAGEMENT ON A REGULAR BASIS AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
STINGRAY THERAPEUTICS
2450 HOLCOMBE BLVD SUITE XHOUSTONTX770212019-04-08$250,000FUNDS WILL BE USED FOR PRECLINICAL WORK FOCUSED ON PEDIATRIC BRAIN CANCERS, INCLUDING WORK TO DEVELOP PRECLINICAL MODELS AND TO TEST COMPOUNDS AGAINST MEDULLOBLASTOMA, AN ULTRA-RARE PEDIATRIC BRAIN CANCER, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE.$250,000NONE, SEE BELOWPRI REPORTS - 3/6/2024, 4/11/2024, 6/12/2024, 1/5/2025, 6/26/20252021-05-18THE TRUSTEES MEET WITH STINGRAY THERAPEUTICS MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY.
THINKMD INC
166 MAIN STREETBURLINGTONVT054012018-05-17$150,000FOR DEVELOPING INTEGRATED CLINICAL ASSESSMENT AND DATA ANALYTICS PLATFORMS AND OTHER DERIVATIVE PRODUCTS THAT TRANSFORM POINT-OF-CARE MEDICINE BY PUTTING VALIDATED CLINICAL ASSESSMENT CAPABILITY AND INCREASED HEALTHCARE KNOWLEDGE INTO THE HANDS OF CLINICALLY UNTRAINED HEALTHCARE PROFESSIONALS AND FAMILIES THEREBY LESSENING THE BURDEN OF THE GOVERNMENT, AND RELIEF OF THE POOR, DISTRESSED AND UNDERPRIVILEGED.$150,000NONE, SEE BELOWPRI REPORTS - 2/1/2024, 6/4/2024, 10/14/2024, 3/31/2025, 5/28/20252019-02-11THE TRUSTEES MEET WITH THINKMD, INC. MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY.

Investments Corp Bonds Schedule InvestmentsCorpBondsSchedule

Investments Corporate Bonds InvestmentsCorporateBondsGrp

FieldValueIRS element (for citing)
BondFIXED INCOMEBondNm
EOY Book Value$17,658,588EOYBookValueAmt
EOYFMV$17,658,588EOYFMVAmt

Investments Corp Stock Schedule InvestmentsCorpStockSchedule

Investments Corporate Stock InvestmentsCorporateStockGrp (2 entries)

StockStockNmEOY Book ValueEOYBookValueAmtEOYFMVEOYFMVAmt
DOMESTIC EQUITIES$34,981,743$34,981,743
FOREIGN SECURITIES$12,360,960$12,360,960

Investments Other Schedule2 InvestmentsOtherSchedule2

Investments Other InvestmentsOtherGrp (2 entries)

Category Or ItemCategoryOrItemTxtListed At Cost Or FMVListedAtCostOrFMVCdBook ValueBookValueAmtEOYFMVEOYFMVAmt
REAL ESTATEFMV$6,061,378$6,061,378
ALTERNATIVE INVESTMENTSFMV$17,615,779$17,615,779

Legal Fees Schedule LegalFeesSchedule

Legal Fees LegalFeesGrp

FieldValueIRS element (for citing)
CategoryLEGAL EXPENSESCategoryTxt
Legal Fees$20,204LegalFeesAmt
Net Investment Income$0NetInvestmentIncomeAmt
Disbursements Charitable Prps$20,204DisbursementsCharitablePrpsAmt

Other Assets Schedule OtherAssetsSchedule

Other Assets Schedule OtherAssetsScheduleGrp

FieldValueIRS element (for citing)
DescPROGRAM RELATED INVESTMENTSDesc
BOY Book Value$4,006,057BOYBookValueAmt
EOY Book Value$4,579,307EOYBookValueAmt
EOYFMV$4,579,307EOYFMVAmt

Other Expenses Schedule OtherExpensesSchedule

Other Expenses Schedule OtherExpensesScheduleGrp (7 entries)

DescDescRevenue And Expenses Per BooksRevenueAndExpensesPerBooksAmtNet Investment IncomeNetInvestmentIncomeAmtDisbursements Charitable PrpsDisbursementsCharitablePrpsAmt
FILING FEES$539$0$539
MISCELLANEOUS EXPENSES$6,623$0$6,623
HRIA ADMINISTRATIVE COSTS$244,367$0$244,367
PROGRAM RELATED INVESTMENT ADMINISTRATIVE COSTS$23,964$0$23,964
MARKETING$4,722$0$4,722
HONORARIA$17,807$0$17,807
TUFTS ADMINISTRATIVE EXPENSES$62,075$0$62,075

Other Income Schedule2 OtherIncomeSchedule2

Other Income Detail OtherIncomeDetail (3 entries)

DescDescRevenue And Expenses Per BooksRevenueAndExpensesPerBooksAmtNet Investment IncomeNetInvestmentIncomeAmtAdjusted Net IncomeAdjustedNetIncomeAmt
INCOME FROM ALTERNATIVE INVESTMENTS$181,544$181,544$181,544
RETURNED GRANTS$26,256$26,256
OTHER INVESTMENT INCOME$882$882

Other Increases Schedule OtherIncreasesSchedule

Other Increases Detail OtherIncreasesDetail

FieldValueIRS element (for citing)
DescUNREALIZED GAINDesc
Amt$3,997,991Amt

Other Professional Fees Schedule OtherProfessionalFeesSchedule

Other Professional Fees Detail OtherProfessionalFeesDetail (2 entries)

CategoryCategoryTxtAmtAmtNet Investment IncomeNetInvestmentIncomeAmtDisbursements Charitable PrpsDisbursementsCharitablePrpsAmt
INVESTMENT FEES - US TRUST$37,630$18,815$18,815
INVESTMENT CONSULTING$78,750$78,750$0

Taxes Schedule TaxesSchedule

Taxes Detail TaxesDetail (3 entries)

CategoryCategoryTxtAmtAmtNet Investment IncomeNetInvestmentIncomeAmtDisbursements Charitable PrpsDisbursementsCharitablePrpsAmt
FEDERAL EXCISE TAXES FOR 2024$105,000$0$0
MA FORM PC FILING FEE$500$0$500
FOREIGN TAXES$40,752$40,752$0

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.